Table 5.

Immune-mediated adverse events (N = 32)

CTCAE ver. 5.0	Any grade, n (%)	Grade 3/4, n (%)
Rash	9 (28.1)	1 (3.1)
Hypothyroidism	7 (21.9)	0
Malaise	6 (18.8)	1 (3.1)
Fever	4 (12.5)	0
Anorexia	4 (12.5)	0
Diarrhea	3 (9.4)	1 (3.1)
Blood corticotrophin increased	3 (9.4)	0
Hyperthyroidism	2 (6.3)	0
ALT increased	2 (6.3)	0
Mucositis oral	2 (6.3)	1 (3.1)
Pneumonitis	2 (6.3)	0
Pruritus	2 (6.3)	0
Increase in blood thyroid-stimulating hormone	2 (6.3)	0
Atrial fibrillation	2 (6.3)	0
Infusion reaction	2 (6.3)	0

ALT, alanine aminotransferase; CTCAE, Common Terminology Criteria for Adverse Events.